These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9164311)

  • 1. In search of a superaspirin for the heart.
    Verheugt FW
    Lancet; 1997 May; 349(9063):1409-10. PubMed ID: 9164311
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet membrane glycoproteins as site of pharmacological intervention in the treatment of coronary disease].
    Neumann FJ; Gawaz M; Schömig A
    Dtsch Med Wochenschr; 1997 Oct; 122(40):1224-30. PubMed ID: 9378047
    [No Abstract]   [Full Text] [Related]  

  • 3. What have We learned from ESPRIT? What will we learn from TARGET?
    Ferguson JJ
    J Invasive Cardiol; 2000 Jun; 12(6):317-9. PubMed ID: 10859719
    [No Abstract]   [Full Text] [Related]  

  • 4. [New antiplatelet agents].
    Diez-Ewald
    Invest Clin; 2000 Sep; 41(3):147-8. PubMed ID: 11029831
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in antiplatelet therapy for acute coronary syndromes.
    Clem JR; Falls S
    S D J Med; 1998 Jul; 51(7):233-4. PubMed ID: 9676157
    [No Abstract]   [Full Text] [Related]  

  • 6. Ischemic coronary syndromes and SVG Interventions--do 2b/3a inhibitors miss the target?
    Topaz O
    Catheter Cardiovasc Interv; 2007 Apr; 69(5):630-1. PubMed ID: 17377986
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelets and coronary intervention: some practical precautions.
    Blankenship JC; Iliadis EA
    J Invasive Cardiol; 2000 Oct; 12(10):536-8. PubMed ID: 11022216
    [No Abstract]   [Full Text] [Related]  

  • 8. Two new antiplatelet drugs for angioplasty and acute coronary syndromes.
    Med Lett Drugs Ther; 1998 Sep; 40(1035):89-90. PubMed ID: 9760948
    [No Abstract]   [Full Text] [Related]  

  • 9. [Abciximab].
    Yokoyama K; Ikeda Y
    Nihon Rinsho; 2006 Oct; 64 Suppl 7():627-9. PubMed ID: 17465067
    [No Abstract]   [Full Text] [Related]  

  • 10. Glycoprotein IIb-IIIa antagonists in percutaneous coronary interventions and acute coronary syndromes.
    Ramanathan A; Kleiman NS
    Indian Heart J; 1998 Oct; 50 Suppl 1():45-56. PubMed ID: 9824907
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of acute ischaemic coronary syndromes beyond aspirin therapy: role of glycoprotein IIb/IIIa antagonists.
    Gambhir DS
    Indian Heart J; 1998; 50(2):151-4. PubMed ID: 9622980
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease.
    Subbarao VD; Phillips J; Stouffer GA
    Am J Med Sci; 1999 Aug; 318(2):107-14. PubMed ID: 10452570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TARGET trial: hit or miss?
    Moliterno DJ; Topol EJ
    Eur Heart J; 2002 Jun; 23(11):835-7. PubMed ID: 12042001
    [No Abstract]   [Full Text] [Related]  

  • 14. [New antithrombotic drugs].
    Taliani MR; Agnelli G
    Recenti Prog Med; 1999 Feb; 90(2):86-93. PubMed ID: 10208099
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical use of glycoprotein IIb/IIIa inhibitors].
    Simonetti I; Gallopin M; Gensini GF
    Ann Ital Med Int; 1998; 13(3):163-8. PubMed ID: 9859573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.
    Adgey AA
    Eur Heart J; 1998 Apr; 19 Suppl D():D10-21. PubMed ID: 9597518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute coronary syndromes: 2. Antiplatelet agents.
    Schneider DJ; Tracy PB; Sobel BE
    Hosp Pract (1995); 1998 May; 33(5):107-10, 115-8, 121-4 passim. PubMed ID: 9606357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GUSTO V: should it affect clinical practice? Global Use of Strategies to Open Occluded Coronary Arteries.
    Orford JL; Berger PB
    Cleve Clin J Med; 2002 Jul; 69(7):520-2. PubMed ID: 12109634
    [No Abstract]   [Full Text] [Related]  

  • 19. [Update on antithrombotic treatments in arterial diseases].
    Fontana P
    Rev Med Suisse; 2007 Feb; 3(97):351-2, 354-6. PubMed ID: 17370734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GP IIb/IIIa inhibitors: an evidence-based approach to their use.
    Med Manag Netw; 1999 Mar; 7(3):5-9. PubMed ID: 10346546
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.